Estatísticas Básicas
| CIK | 884363 |
SEC Filings
All companies that sell securities in the United States must register with the Securities and Exchange Commission (SEC) and file reports on a regular basis.
These reports include company annual reports (10K, 10Q), news updates (8K), investor presentations (found in 8Ks), insider trades (form 4), ownership reports (13D, and 13G), and reports related to the specific securities sold, such as registration statements and prospectus. This page shows recent SEC filings related to Evolutionary Genomics, Inc.
SEC Filings (Chronological Order)
Esta página fornece uma lista completa e cronológica de Arquivamentos da SEC, excluindo os arquivamentos de propriedade que fornecemos em outro lugar.
| April 28, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 15 CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION UNDER SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR SUSPENSION OF DUTY TO FILE REPORTS UNDER SECTIONS 13 AND 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934. Commission File Number: 000-54129 Evolutionary Genomics, Inc. (Exact name of registrant as specifie |
|
| March 9, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ——————— FORM 10-K ——————— ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended: December 31, 2022 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from: to Evolutionary Genomics, Inc. (Exact name o |
|
| October 21, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ??????? FORM 10-Q ??????? (Mark One) ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED SEPTEMBER 30, 2022 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO EVOLUTIONARY GENOMICS, |
|
| August 8, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ——————— FORM 10-Q ——————— (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED JUNE 30, 2022 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO EVOLUTIONARY GENOMICS, INC. |
|
| May 16, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ??????? FORM 10-Q ??????? (Mark One) ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED MARCH 31, 2022 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO EVOLUTIONARY GENOMICS, INC. |
|
| March 31, 2022 |
Unregistered Sales of Equity Securities, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ——————— FORM 8-K ——————— CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 24, 2022 ——————— EVOLUTIONARY GENOMICS, INC. (Exact name of registrant as specified in its charter) ——————— Nevada 000-54129 26-4369698 (State or Other Jurisdict |
|
| March 31, 2022 |
Common Stock Subscription Agreement EXHIBIT 4.2 THE SECURITIES OFFERED INVOLVE A HIGH DEGREE OF RISK AND MAY RESULT IN THE LOSS OF YOUR ENTIRE INVESTMENT. ANY PERSON CONSIDERING THE PURCHASE OF THESE SECURITIES SHOULD CONSULT WITH HIS, HER OR ITS LEGAL, TAX AND FINANCIAL ADVISORS PRIOR TO MAKING AN INVESTMENT IN SECURITIES. THE SECURITIES SHOULD ONLY BE PURCHASED BY PERSONS WHO CAN AFFORD TO LOSE ALL OF THEIR INVESTMENT. SUBSCRIPTIO |
|
| March 31, 2022 |
Preferred Stock Subscription Agreement EXHIBIT 4.1 THE SECURITIES OFFERED INVOLVE A HIGH DEGREE OF RISK AND MAY RESULT IN THE LOSS OF YOUR ENTIRE INVESTMENT. ANY PERSON CONSIDERING THE PURCHASE OF THESE SECURITIES SHOULD CONSULT WITH HIS, HER OR ITS LEGAL, TAX AND FINANCIAL ADVISORS PRIOR TO MAKING AN INVESTMENT IN SECURITIES. THE SECURITIES SHOULD ONLY BE PURCHASED BY PERSONS WHO CAN AFFORD TO LOSE ALL OF THEIR INVESTMENT. SUBSCRIPTIO |
|
| March 22, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ——————— FORM 10-K ——————— ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended: December 31, 2021 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from: to Evolutionary Genomics, Inc. (Exact name o |
|
| November 1, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ??????? FORM 10-Q ??????? (Mark One) ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED SEPTEMBER 30, 2021 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO EVOLUTIONARY GENOMICS, |
|
| August 6, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ——————— FORM 10-Q ——————— (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED JUNE 30, 2021 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO EVOLUTIONARY GENOMICS, INC. |
|
| May 13, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ??????? FORM 10-Q ??????? (Mark One) ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED MARCH 31, 2021 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO EVOLUTIONARY GENOMICS, INC. |
|
| March 31, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ??????? FORM 10-K ??????? ? ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended: December 31, 2020 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from: to Evolutionary Genomics, Inc. (Exact name o |
|
| November 13, 2020 |
Development and Commercialization Agreement EXHIBIT 10.1 |
|
| November 13, 2020 |
Quarterly Report - QUARTERLY REPORT UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ——————— FORM 10-Q ——————— (Mark One) þ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED SEPTEMBER 30, 2020 OR ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO Commission File Number: |
|
| November 13, 2020 |
Standard Research Agreement EXHIBIT 10.2 |
|
| August 19, 2020 |
Quarterly Report - QUARTERLY REPORT Quarterly Report UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ——————— FORM 10-Q ——————— (Mark One) þ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED JUNE 30, 2020 OR ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO Commission |
|
| August 14, 2020 |
Form 12b-25 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 SEC FILE NUMBER NOTIFICATION OF LATE FILING CUSIP NUMBER (Check one): Form 10-K Form 20-F Form 11-K ü Form 10-Q Form 10-D Form N-CEN Form N-CSR For Period Ended: June 30, 2020 Transition Report on Form 10-K Transition Report on Form 20-F Transition Report on Form 11-K Transition Report on Form 10-Q For |
|
| May 12, 2020 |
Quarterly Report - QUARTERLY REPORT Quarterly Report UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ——————— FORM 10-Q ——————— (Mark One) þ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED MARCH 31, 2020 OR ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO Commission |
|
| April 24, 2020 |
10-K/A 1 fnam10k.htm 10-K/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ——————— FORM 10-K/A (Amendment No. 1) ——————— þ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended: December 31, 2019 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period fr |
|
| March 30, 2020 |
Notice of Termination–Sponsored Research Agreement Notice of Termination EXHIBIT 10.13 |
|
| March 30, 2020 |
FNAM / Evolutionary Genomics, Inc. 10-K - Annual Report - ANNUAL REPORT Annual Report UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ——————— FORM 10-K ——————— þ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended: December 31, 2019 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from: to Evolutionary Genomics, Inc. |
|
| March 30, 2020 |
Certificate of Designations, Preferences and Rights of Series A-2 Preferred Stock EXHIBIT 3.4 EVOLUTIONARY GENOMICS, INC. CERTIFICATE OF DESIGNATION OF PREFERENCES, RIGHTS AND LIMITATIONS OF SERIES A-2 CONVERTIBLE PREFERRED STOCK The undersigned, the Chief Executive Officer of Evolutionary Genomics, Inc., a Nevada corporation (the “Corporation”), in accordance with the provisions of the Nevada Revised Statutes, does hereby certify: That pursuant to the authority conferred upon |
|
| October 17, 2019 |
FNAM / Evolutionary Genomics, Inc. 10-Q - Quarterly Report - QUARTERLY REPORT 10-Q 1 fnam10q.htm QUARTERLY REPORT UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ——————— FORM 10-Q ——————— (Mark One) þ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED SEPTEMBER 30, 2019 OR ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PE |
|
| August 12, 2019 |
FNAM / Evolutionary Genomics, Inc. 10-Q - Quarterly Report - QUARTERLY REPORT 10-Q 1 fnam10q.htm QUARTERLY REPORT UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ——————— FORM 10-Q ——————— (Mark One) þ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED JUNE 30, 2019 OR ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD |
|
| May 15, 2019 |
FNAM / Evolutionary Genomics, Inc. 10-Q Quarterly Report QUARTERLY REPORT 10-Q 1 fnam10q.htm QUARTERLY REPORT UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ——————— FORM 10-Q ——————— (Mark One) þ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED MARCH 31, 2019 OR ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD |
|
| April 1, 2019 |
FNAM / Evolutionary Genomics, Inc. ANNUAL REPORT (Annual Report) Annual Report UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ——————— FORM 10-K ——————— þ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended: December 31, 2018 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from: to Evolutionary Genomics, Inc. |
|
| April 1, 2019 |
Wisconsin Crop Innovation Center Service Agreement and Amendment Wisconsin Crop Innovation Center Service Agreement and Amendment EXHIBIT 10.11 |
|
| April 1, 2019 |
State of Colorado Grant Agreement EX-10.12 3 fnamex10z12.htm STATE OF COLORADO GRANT AGREEMENT EXHIBIT 10.12 |
|
| November 14, 2018 |
FNAM / Evolutionary Genomics, Inc. QUARTERLY REPORT (Quarterly Report) Quarterly Report UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ——————— FORM 10-Q ——————— (Mark One) þ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED SEPTEMBER 30, 2018 OR ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO Commis |
|
| October 4, 2018 |
Financial Statements and Exhibits, Changes in Registrant's Certifying Accountant 8-K 1 fnam8k.htm CURRENT REPORT UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ——————— FORM 8-K ——————— CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 1, 2018 ——————— EVOLUTIONARY GENOMICS, INC. (Exact name of registrant as specified in its charter) ——————— Nevada 000-54129 26- |
|
| October 4, 2018 |
Auditor Letter dated October 4, 2018 EX-16.1 2 fnamex16z1.htm AUDITOR LETTER EXHIBIT 16.1 October 4, 2018 Securities and Exchange Commission Washington, D.C. 20549 Commissioners: We have read Evolutionary Genomics, Inc.’s statements included under Item 4.01 of its Form 8-K filed on October 4, 2018 and we agree with such statements concerning our firm. EKS&H LLLP |
|
| July 27, 2018 |
FNAM / Evolutionary Genomics, Inc. QUARTERLY REPORT (Quarterly Report) Quarterly Report UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ——————— FORM 10-Q ——————— (Mark One) þ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED JUNE 30, 2018 OR ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO Commission |
|
| May 21, 2018 |
Current Report UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ——————— FORM 8-K ——————— CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 17, 2018 ——————— EVOLUTIONARY GENOMICS, INC. (Exact name of registrant as specified in its charter) ——————— Nevada 000-54129 26-4369698 (State or Ot |
|
| May 15, 2018 |
FNAM / Evolutionary Genomics, Inc. QUARTERLY REPORT (Quarterly Report) Quarterly Report UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ——————— FORM 10-Q ——————— (Mark One) þ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED MARCH 31, 2018 OR ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO Commission |
|
| March 5, 2018 |
FNAM / Evolutionary Genomics, Inc. QUARTERLY REPORT (Annual Report) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ——————— FORM 10-K ——————— þ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended: December 31, 2017 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from: to Evolutionary Genomics, Inc. (Exact name o |
|
| March 5, 2018 |
Subsidiaries of Evolutionary Genomics, Inc. Subsidiaries EXHIBIT 21.1 Subsidiaries Name of Subsidiary Jurisdiction EG Crop Science, Inc. Delaware ICAM Therapeutics, Inc. Delaware |
|
| November 13, 2017 |
FNAM / Evolutionary Genomics, Inc. QUARTERLY REPORT (Quarterly Report) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ——————— FORM 10-Q ——————— (Mark One) þ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED SEPTEMBER 30, 2017 OR ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO Commission File Number: |
|
| August 3, 2017 |
FNAM / Evolutionary Genomics, Inc. QUARTERLY REPORT (Quarterly Report) Quarterly Report UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ——————— FORM 10-Q ——————— (Mark One) þ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED JUNE 30, 2017 OR ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO Commission |
|
| May 11, 2017 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q Quarterly Report UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ——————— FORM 10-Q ——————— (Mark One) þ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED MARCH 31, 2017 OR ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO Commission |
|
| February 10, 2017 |
Amendment 1 to the UM Nguyen Sponsored Research Contract EXHIBIT 10.9 Agreement Amendment #1 Effective September 16, 2016, this is Amendment # I to the Sponsored Research Contract, fully executed on 3/17/2015, originally signed between the E G Crop Science, Inc. (previously known as Evolutionary Genomics, Inc.), with its principal offices at 1801 Sunset Place, Unit C, Longmont CO 80501 and The Curators of the University of Missouri-Columbia with its pri |
|
| February 10, 2017 |
Name of Subsidiary Jurisdiction EG Crop Science, Inc. Delaware ICAM Therapeutics, Inc. Delaware Subsidiaries EXHIBIT 21.1 Subsidiaries Name of Subsidiary Jurisdiction EG Crop Science, Inc. Delaware ICAM Therapeutics, Inc. Delaware |
|
| February 10, 2017 |
Annual Report UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ——————— FORM 10-K ——————— þ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended: December 31, 2016 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from: to Commission file number: 000 |
|
| February 10, 2017 |
Amendment 2 to the UM Zhang Sponsored Research Contract EX-10.10 3 fnamex10z10.htm AGREEMENT AMENDMENT #2 EXHIBIT 10.10 Agreement Amendment #2 Effective May 20th, 2016, this is Amendment #2 to further amend the Sponsored Research Contract, fully executed on 12124/14 and amended by Amendment #1 on 4/13/16, between the E G Crop Science, Inc. (previously known as Evolutionary Genomics, Inc.),with its principal offices at 1801 Sunset Place, Unit C, Longmon |
|
| November 4, 2016 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q 10-Q 1 fnam10q.htm QUARTERLY REPORT UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ——————— FORM 10-Q ——————— (Mark One) þ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED SEPTEMBER 30, 2016 OR ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PE |
|
| September 9, 2016 |
Current Report UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ??????? FORM 8-K ??????? CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 9, 2016 ??????? EVOLUTIONARY GENOMICS, INC. (Exact name of registrant as specified in its charter) ??????? Nevada 000-54129 26-4369698 (State |
|
| August 12, 2016 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q Quarterly Report UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ——————— FORM 10-Q ——————— (Mark One) þ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED JUNE 30, 2016 OR ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO Commission |
|
| May 11, 2016 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q Quarterly Report UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ——————— FORM 10-Q ——————— (Mark One) þ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED MARCH 31, 2016 OR ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO Commission |
|
| February 25, 2016 |
FORM OF SUBSCRIPTION AGREEMENT EXHIBIT 10.1 THE SECURITIES OFFERED INVOLVE A HIGH DEGREE OF RISK AND MAY RESULT IN THE LOSS OF YOUR ENTIRE INVESTMENT. ANY PERSON CONSIDERING THE PURCHASE OF THESE SECURITIES SHOULD CONSULT WITH HIS, HER OR ITS LEGAL, TAX AND FINANCIAL ADVISORS PRIOR TO MAKING AN INVESTMENT IN SECURITIES. THE SECURITIES SHOULD ONLY BE PURCHASED BY PERSONS WHO CAN AFFORD TO LOSE ALL |
|
| February 25, 2016 |
Evolutionary Genomics CURRENT REPORT (Current Report/Significant Event) Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ??????? FORM 8-K ??????? CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 25, 2016 (February 22, 2016) ??????? EVOLUTIONARY GENOMICS, INC. (Exact name of registrant as specified in its charter) ??????? Nevada 000-54129 41-1 |
|
| February 25, 2016 |
Certificate of Designations, Preferences and Rights of Series A-1 Preferred Stock EX-3.1 2 fnamex3z1.htm CERTIFICATE OF DESIGNATIONS, PREFERENCES AND RIGHTS OF SERIES A-1 PREFERRED STOCK EXHIBIT 3.1 EVOLUTIONARY GENOMICS, INC. CERTIFICATE OF DESIGNATION OF PREFERENCES, RIGHTS AND LIMITATIONS OF SERIES A-1 CONVERTIBLE PREFERRED STOCK The undersigned, the Chief Executive Officer of Evolutionary Genomics, Inc., a Nevada corporation (the “Corporation”), in accordance with the provi |
|
| February 25, 2016 |
Evolutionary Genomics AMENDED ANNUAL REPORT (Annual Report) Amended Annual Report UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. |
|
| February 19, 2016 |
State of Colorado Grant Agreement Exhibit 10.8 CMS #: Fund: 27L0 Unit: AIPU Subunit: AIGR Approp: ECAAB7110 Function: ESCR Object: 5781 Encumbrance #: Grant $: 250,000 Dates: to 5/1/18 STATE OF COLORADO OFFICE OF ECONOMIC DEVELOPMENT AND INTERNATIONAL TRADE Grant Agreement with Evolutionary Genomics, Inc. I TABLE OF CONTENTS 1 1. PARTIES 1 2. EFFECTIVE DATE AND NOTICE OF NONLIABILITY 1 3. RECITALS 1 4. DEFINITIONS 2 5. TERM and EA |
|
| February 19, 2016 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ——————— FORM 10-K ——————— þ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended: December 31, 2015 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from: to Commission file number: 000-54129 Evoluti |
|
| February 19, 2016 |
Name of Subsidiary Jurisdiction Evolutionary Genomics, Inc. Delaware EX-21.1 3 fnamex21z1.htm SUBSIDIARIES EXHIBIT 21.1 Subsidiaries Name of Subsidiary Jurisdiction Evolutionary Genomics, Inc. Delaware |
|
| October 23, 2015 |
8-K 1 fnam8k.htm CURRENT REPORT UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ——————— FORM 8-K ——————— CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 23, 2015 (October 19, 2015) ——————— EVOLUTIONARY GENOMICS, INC. (Exact name of registrant as specified in its charter) ——————— |
|
| October 23, 2015 |
Auditor Letter EXHIBIT 16.1 SCHUMACHER & ASSOCIATES, INC. Certified Public Accountants 7931 S. Broadway, #314 Littleton, CO 80122 (303) 480-5037 FAX (303) 379-5394 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM Dear Commissioners: We have read the statements included under Item 4.01 ?Changes in Registrant?s Certifying Accountant? in the Form 8-K to be filed with the U.S. Securities and E |
|
| October 23, 2015 |
EX-4.1 3 fnamex4z1.htm SPECIMEN STOCK CERTIFICATE EXHIBIT 4.1 Number Shares CUSIP 30051F 10 1 EVOLUTIONARY GENOMICS, INC. SEE REVERSE FOR INCORPORATED UNDER THE LAWS OF THE STATE OF NEVADA CERTAIN DEFINITIONS AUTHORIZED: 780,000,000 COMMON SHARES, $0.001 PAR VALUE PER SHARE This Certifies that is the owner of Fully Paid and Non-Assessable Common Stock, $0.001 Par Value of EVOLUTIONARY GENOMICS, IN |
|
| October 23, 2015 |
Subsidiaries of Evolutionary Genomics, Inc., a Nevada corporation EX-21.1 5 fnamex21z1.htm SUBSIDIARIES Exhibit 21.1 Subsidiaries of Evolutionary Genomics, Inc., a Nevada corporation 1. EG I, LLC, a Colorado LLC 2. Evolutionary Genomics, Inc., a Delaware corporation |
|
| October 23, 2015 |
Form of Amended and Restated Articles of Incorporation EX-3.1 2 fnamex3z1.htm AMENDED AND RESTATED ARTICLES OF INCORPORATION EXHIBIT 3.1 AMENDED AND RESTATED ARTICLES OF INCORPORATION OF EVOLUTIONARY GENOMICS, INC. Evolutionary Genomics, Inc. (the “Corporation”), formerly known as Fona, Inc., a corporation incorporated under the laws of the state of Nevada on February 4, 2009, hereby amends and restates its Articles of Incorporation, to embody in one |
|
| October 6, 2015 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q Quarterly Report UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ——————— FORM 10-Q ——————— (Mark One) þ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED SEPTEMBER 30, 2015 OR ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO Commis |
|
| September 30, 2015 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ??????? FORM 8-K ??????? CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 30, 2015 (September 30, 2015) ??????? FONA, INC. (Exact name of registrant as specified in its charter) ??????? Nevada 000-54129 41-1683548 (State or Other J |
|
| September 11, 2015 |
424B3 1 fnam424b.htm 424B3 Filed pursuant to Rule 424(b)(3) Registration No. 333-203196 Fona, Inc. 1026 Anaconda Drive Castle Rock, Colorado 80108 MERGERS PROPOSED—YOUR VOTE IS VERY IMPORTANT As we previously announced, Fona, Inc. (“Fona”), Evolutionary Genomics, Inc. (“Evolutionary Genomics”) and EG I, LLC (“EG I”) have entered into the Amended and Restated Agreement and Plan of Merger dated Marc |
|
| September 9, 2015 |
Acceleration Request Fona, Inc. 1026 Anaconda Drive Castle Rock, Colorado 80108 (720) 900-8666 September 9, 2015 VIA EDGAR United States Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, DC 20549 Attn: Jeffrey P. Riedler Re: Fona, Inc. Registration Statement on Form S-4 Filed April 2, 2015, as amended File No. 333-203196 Dear Mr. Riedler: Pursuant to |
|
| August 28, 2015 |
As filed with the Securities and Exchange Commission on August 27, 2015 S-4/A As filed with the Securities and Exchange Commission on August 27, 2015 Registration No. |
|
| August 28, 2015 |
FONA, INC. A NEVADA CORPORATION ANNUAL MEETING OF STOCKHOLDERS ____, 2015 COMMON STOCK BALLOT EXHIBIT 99.1 FONA, INC. A NEVADA CORPORATION ANNUAL MEETING OF STOCKHOLDERS , 2015 COMMON STOCK BALLOT Name of Stockholder(s): (Please Print) Name of Proxy, if applicable: (Please Print) Indicate by an ?x? if proxy has been previously executed and submitted and is revoked hereby: Number of shares: 1. To elect three directors to serve on the Company?s Board of Directors, each to serve until the nex |
|
| August 4, 2015 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ??????? FORM 10-Q ??????? (Mark One) ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED June 30, 2015 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO Commission File Number: 000- |
|
| July 30, 2015 |
FONA, INC. A NEVADA CORPORATION ANNUAL MEETING OF STOCKHOLDERS ____, 2015 COMMON STOCK BALLOT EX-99.1 4 fnamex99z1.htm FORM OF PROXY CARD EXHIBIT 99.1 FONA, INC. A NEVADA CORPORATION ANNUAL MEETING OF STOCKHOLDERS , 2015 COMMON STOCK BALLOT Name of Stockholder(s): (Please Print) Name of Proxy, if applicable: (Please Print) Indicate by an “x” if proxy has been previously executed and submitted and is revoked hereby: Number of shares: 1. To elect three directors to serve on the Company’s Boa |
|
| July 30, 2015 |
As filed with the Securities and Exchange Commission on July 30, 2015 S-4/A As filed with the Securities and Exchange Commission on July 30, 2015 Registration No. |
|
| July 30, 2015 |
SEC Response Letter July 30, 2015 VIA EDGAR U.S. Securities and Exchange Commission Division of Investment Management 100 F Street, N.E. Washington, DC 20549 Attn: Jeffrey P. Riedler, Assistant Director Re: Fona, Inc. Amendment No. 1 to Joint Registration Statement and Proxy Statement on Form S-4 Filed July 2, 2015 File No. 333-203196 Dear Mr. Riedler: Fona, Inc. (the “Company”, “Fona”, “it”, “we” |
|
| July 21, 2015 |
July 21, 2015 Via E-mail Steve B. Warnecke Chief Executive Officer and President Fona, Inc. 1026 Anaconda Drive Castle Rock, Colorado 80108 Re: Fona, Inc. Amendment No. 1 to Joint Registration Statement and Proxy Statement on Form S-4 Filed July 2, 2015 File No. 333-203196 Dear Mr. Warnecke: We have reviewed your joint registration statement and proxy statement and have the following comments. In |
|
| July 6, 2015 |
Response Letter VIA EDGAR July 2, 2015 U.S. Securities and Exchange Commission Division of Investment Management 100 F Street, N.E. Washington, DC 20549 Attn: Jeffrey P. Riedler, Assistant Director RE: Fona, Inc. Joint Registration Statement and Proxy Statement on Form S-4 Filed April 2, 2015 File No. 333-203196 Dear Mr. Riedler: Fona, Inc. (the ?Company?, ?Fona?, ?it?, ?we?, ?us? or ?our?) hereby |
|
| July 2, 2015 |
As filed with the Securities and Exchange Commission on July 2, 2015 S-4/A 1 fnams4.htm REGISTRATION STATEMENT As filed with the Securities and Exchange Commission on July 2, 2015 Registration No. 333-203196 SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ——————— AMENDMENT NO. 1 TO FORM S-4 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 ——————— Fona, Inc. (Exact name of registrant as specified in its charter) Nevada 6770 41-1683548 (State or othe |
|
| July 2, 2015 |
Contract for Services University of Missouri EXHIBIT 10.5 SPONSORED RESEARCH CONTRACT THE CURATORS OF THE UNIVERSITY OF MISSOURI This Contract (the ?Contract?) by and between The Curators of the University of Missouri on behalf of the University of Missouri with its principal offices at 310 Jesse Hall, Office of Sponsored Programs Administration, Columbia, Missouri 65211-1230 (?University?) and Evolutionary Genomics, Inc. with its principal |
|
| July 2, 2015 |
FONA, INC. A NEVADA CORPORATION ANNUAL MEETING OF STOCKHOLDERS ____, 2015 COMMON STOCK BALLOT EX-99.1 10 fnamex99z1.htm FORM OF PROXY CARD EXHIBIT 99.1 FONA, INC. A NEVADA CORPORATION ANNUAL MEETING OF STOCKHOLDERS , 2015 COMMON STOCK BALLOT Name of Stockholder(s): (Please Print) Name of Proxy, if applicable: (Please Print) Indicate by an “x” if proxy has been previously executed and submitted and is revoked hereby: Number of shares: 1. To elect three directors to serve on the Company’s Bo |
|
| July 2, 2015 |
Bill and Melinda Gates Foundation MSA EX-10.6 6 fnamex10z6.htm MASTER SERVICES AGREEMENT EXHIBIT 10.6 MASTER SERVICES AGREEMENT Consultant: Evolutionary Genomics Inc Contact Name: Walter Messier Address: 1376 Miners Drive Lafayette, CO 80026 UNITED STATES Telephone Numbers: (303) 862-3222 Ext. 302 Email Address: [email protected] Foundation Address: Standard Mail: PO Box 23350, Seattle, WA 98102 Courier: 1432 Elliott Avenue West, S |
|
| July 2, 2015 |
Fee for Services Agreement University of Missouri EX-10.4 4 fnamex10z4.htm FEE FOR SERVICE AGREEMENT EXHIBIT 10.4 Fee for Service Agreement This Agreement (the “Agreement”) by and between The Curators of the University of Missouri on behalf of the University of Missouri–Columbia with its principal offices at 310 Jesse Hall, Office of Sponsored Programs Administration, Columbia, Missouri 65211-1230 (“University”) and Evolutionary Genomics, Inc., w |
|
| July 2, 2015 |
Bill and Melinda Gates Foundation WO 1 EXHIBIT 10.7 WORK ORDER #1 Ortholog Identification & Validation in Beans & Cowpeas Consultant: Evolutionary Genomics Inc Work Order Effective Date: November 1, 2012 Work Order Expiration Date: August 31, 2014 Master Services Agreement Effective Date: November 1, 2012 Contract #: 22667 This Work Order is agreed pursuant to and made a part of the Master Services Agreement (the ?Agreement?) reference |
|
| July 2, 2015 |
Tennessee State University Agreement EXHIBIT 10.2 Phenotyping of Cowpea and Common Beans for Evolutionary Genomics Principal Investigator: Dr. Matthew W. Blair (Research Associate Professor) / TSU) Principal Institution: Tennessee State University, Department of Agriculture and Natural Sciences, Lawson Hall, 3500 John A. Merritt Blvd. / Nashville TN Granting Entity: Evolutionary Genomics / Lafayette, CO Principal Grant Contact: Dr. W |
|
| July 2, 2015 |
Tennessee State University Amendment EX-10.3 3 fnamex10z3.htm TENNESSEE STATE UNIVERSITY AMENDMENT EXHIBIT 10.3 Amendment to Contract Title: Root Transformation Gene Expression and Nematode Resistance Studies in Common Beans for Evolutionary Genomics Principal Investigator: Dr. Matthew W. Blair (Research Associate Professor) / TSU, Nashville, USA Visiting Scholar: Dr. Xue Renfeng (Subdirector Legumes) / LAAS, Shenyang, China Principa |
|
| May 14, 2015 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ——————— FORM 10-Q ——————— (Mark One) þ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED MARCH 31, 2015 OR ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO Commission File Number: 000 |
|
| May 1, 2015 |
May 1, 2015 Via E-mail Steve B. Warnecke Chief Executive Officer and President Fona, Inc. 1026 Anaconda Drive Castle Rock, Colorado 80108 Re: Fona, Inc. Joint Registration Statement and Proxy Statement on Form S-4 Filed April 2, 2015 File No. 333-203196 Dear Mr. Warnecke: We have reviewed your joint registration statement and proxy statement and have the following comments. In some of our comments |
|
| April 2, 2015 |
AMENDED AND RESTATED ARTICLES OF INCORPORATION EG HOLDINGS, INC. AMENDED AND RESTATED ARTICLES OF INCORPORATION EXHIBIT 3.1 AMENDED AND RESTATED ARTICLES OF INCORPORATION OF EG HOLDINGS, INC. EG Holdings, Inc. (the “Corporation”), formerly known as Fona, Inc., a corporation incorporated under the laws of the state of Nevada on February 4, 2009, hereby amends and restates its Articles of Incorporation, to embody in one document its original articles and the subs |
|
| April 2, 2015 |
FONA, INC. A NEVADA CORPORATION ANNUAL MEETING OF STOCKHOLDERS ____, 2015 COMMON STOCK BALLOT EXHIBIT 99.1 FONA, INC. A NEVADA CORPORATION ANNUAL MEETING OF STOCKHOLDERS , 2015 COMMON STOCK BALLOT Name of Stockholder(s): (Please Print) Name of Proxy, if applicable: (Please Print) Indicate by an ?x? if proxy has been previously executed and submitted and is revoked hereby: Number of shares: 1. To elect three directors to serve on the Company?s Board of Directors, each to serve until the nex |
|
| April 2, 2015 |
As filed with the Securities and Exchange Commission on April 2, 2015 S-4 As filed with the Securities and Exchange Commission on April 2, 2015 Registration No. |
|
| April 2, 2015 |
2014 EQUITY INCENTIVE PLAN EXHIBIT 10.1 EG HOLDINGS, INC. 2015 EQUITY INCENTIVE PLAN 1. Purpose. The purpose of the EG Holdings, Inc. 2015 Equity Incentive Plan is to provide a means through which the Company and its Affiliates may attract and retain key personnel and to provide a means whereby directors, officers, employees, consultants and advisors (and prospective directors, officers, employees |
|
| March 5, 2015 |
Annual Report UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ——————— FORM 10-K ——————— þ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended: December 31, 2014 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from: to Commission file number: 000 |
|
| March 5, 2015 |
Amended and Restated Agreement and Plan of Merger AMENDED AND RESTATED AGREEMENT AND PLAN OF MERGER EXHIBIT 10.1 AMENDED AND RESTATED AGREEMENT AND PLAN OF MERGER THIS AMENDED AND RESTATED AGREEMENT AND PLAN OF MERGER (the “Agreement”) is made and entered into this 2nd day of March, 2015 (the “Execution Date”), by and among Fona, Inc., a Nevada Corporation (“Parent”), Fona Merger Sub, Inc., a Delaware Corporation (“Sub”), Fona Merger Sub, LLC, a |
|
| November 14, 2014 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q Quarterly Report UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ——————— FORM 10-Q ——————— (Mark One) þ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED September 30, 2014 OR ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO Commis |
|
| October 17, 2014 |
FNAM / Evolutionary Genomics, Inc. SC 14F1 - - INFORMATION STATEMENT SC 14F1 1 fnamsc14f1.htm INFORMATION STATEMENT UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14F-1 INFORMATION STATEMENT PURSUANT TO SECTION 14(F) OF THE SECURITIES EXCHANGE ACT OF 1934 AND RULE 14F-1 THEREUNDER FONA, INC. (Exact name of registrant as specified in its corporate charter) Nevada 000-54129 41-1683548 (State or other jurisdiction of incorporation) (C |
|
| October 8, 2014 |
Entry into a Material Definitive Agreement Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ——————— Amendment No. 1 FORM 8-K/A ——————— CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 8, 2014 (October 1, 2014) ——————— FONA, INC. (Exact name of registrant as specified in its charter) ——————— Nevada 000-54129 41-1683 |
|
| October 8, 2014 |
Schedule 13D/A SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 1)* FONA, INC. (Name of Issuer) Common Stock, $.001 par value. (Title of Class of Securities) 344434 10 5 (CUSIP Number) Steve B. Warnecke 1026 Anaconda Drive Castle Rock, CO 80302 (303) 513-3510 (Name, Address and Telephone Number of Person Authorized to R |
|
| October 8, 2014 |
Securities Purchase Agreement EXHIBIT 99.2 SECURITIES PURCHASE AGREEMENT This SECURITIES PURCHASE AGREEMENT (the “Agreement”) is made and entered into as of the 1st day of October, 2014, by and among Michael Friess (“Friess”), Sanford Schwartz (“Schwartz”), Nick Boosalis (“Boosalis”), Desfaire, Inc., a Minnesota corporation (“Desfaire”), The Boosalis Group, Inc., a Minnesota corporation (“The Boos |
|
| October 8, 2014 |
EX-99.1 2 fnamex99z1.htm JOINT FILING AGREEMENT Exhibit 99.1 JOINT FILING AGREEMENT In accordance with Rule 13d-1(k) under the Securities Exchange Act of 1934, as amended, the undersigned agree to the joint filing on behalf of each of them of a Statement on Schedule 13D (including any and all amendments thereto) with respect to the common stock, $0.001 par value, of Fona, Inc., and further agree t |
|
| October 7, 2014 |
Securities Purchase Agreement EXHIBIT 2.1 SECURITIES PURCHASE AGREEMENT This SECURITIES PURCHASE AGREEMENT (the “Agreement”) is made and entered into as of the 1st day of October, 2014, by and among Michael Friess (“Friess”), Sanford Schwartz (“Schwartz”), Nick Boosalis (“Boosalis”), Desfaire, Inc., a Minnesota corporation (“Desfaire”), The Boosalis Group, Inc., a Minnesota corporation (“The Boosa |
|
| October 7, 2014 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ——————— FORM 8-K ——————— CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 7, 2014 (October 1, 2014) ——————— FONA, INC. (Exact name of registrant as specified in its charter) ——————— Nevada 000-54129 41-1683548 (State or Other Jurisdi |
|
| August 19, 2014 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q Quarterly Report UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ——————— FORM 10-Q ——————— (Mark One) þ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED June 30, 2014 OR ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO Commission |
|
| August 14, 2014 |
FNAM / Evolutionary Genomics, Inc. NT 10-Q - - NOTIFICATION OF LATE FILING Notification of Late Filing UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. |
|
| June 16, 2014 |
SECURITIES PURCHASE OPTION AGREEMENT Exhibit 99.3 SECURITIES PURCHASE OPTION AGREEMENT This SECURITIES PURCHASE OPTION AGREEMENT (the “Agreement”) is made and entered into as of the 6th day of June, 2014, by and among Nick Boosalis, a resident of the state of Minnesota (“Boosalis”), Desfaire, Inc., a Minnesota corporation (“Desfaire”), The Boosalis Group, Inc., a Minnesota corporation (“The Boosalis Group”, together with Boosalis and |
|
| June 16, 2014 |
FNAM / Evolutionary Genomics, Inc. / Evolutionary Genomics, Inc. - SCHEDULE 13D Activist Investment SC 13D 1 sc13d0614evolutionaryfona.htm SCHEDULE 13D SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. )* FONA, INC. (Name of Issuer) Common Stock, $.001 par value. (Title of Class of Securities) 344434 10 5 (CUSIP Number) Michael Friess 2575 Pearl Street, Suite 225, Boulder, Colorado 80302 (303) 499-6000 (Name, Address a |
|
| June 16, 2014 |
EX-99.1 2 sc13d0614ex99ifona.htm JOINT FILING AGREEMENT Exhibit 99.1 JOINT FILING AGREEMENT In accordance with Rule 13d-1(k) under the Securities Exchange Act of 1934, as amended, the undersigned agree to the joint filing on behalf of each of them of a Statement on Schedule 13D (including any and all amendments thereto) with respect to the common stock, $0.001 par value, of Fona, Inc., and further |
|
| June 16, 2014 |
Exhibit 99.2 SECURITIES PURCHASE AGREEMENT This SECURITIES PURCHASE AGREEMENT (the “Agreement”) is made and entered into as of the 6th day of June, 2014, by and among Michael Friess (“Friess”), Sanford Schwartz (“Schwartz”, together with Friess, each a “Seller” and collectively, the “Sellers”) and Evolutionary Genomics, Inc. (the “Buyer”). W I T N E S S E T H: WHEREAS, Sellers own, in the aggregat |
|
| June 12, 2014 |
Exhibit 2.1 AGREEMENT AND PLAN OF MERGER THIS AGREEMENT AND PLAN OF MERGER (the “Agreement”) is made and entered into this 6th day of June, 2014 (the “Execution Date”), by and among Fona, Inc., a Nevada Corporation (“Parent”), Fona Merger Sub, Inc., a Delaware Corporation (“Sub”), Fona Merger Sub, LLC, a Colorado limited liability company (“Sub LLC”, together with Sub and Parent, collectively the |
|
| June 12, 2014 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): June 12, 2014 (June 6, 2014) FONA, INC. (Exact Name of Registrant Specified in Charter) Nevada 000-54129 41-1683548 (State or Other Jurisdiction of Incorporation) (Commission File Num |
|
| May 12, 2014 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q Quarterly Report UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ——————— FORM 10-Q ——————— (Mark One) þ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED MARCH 31, 2014 OR ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO Commission |
|
| April 16, 2014 |
Annual Report UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ——————— FORM 10-K ——————— þ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended: December 31, 2013 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from: to Commission file number: 000 |
|
| March 25, 2014 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 SEC FILE NUMBER NOTIFICATION OF LATE FILING CUSIP NUMBER (Check one): X Form 10-K Form 20-F Form 11-K Form 10-Q Form 10-D Form N-SAR Form N-CSR For Period Ended: December 31, 2013 Transition Report on Form 10-K Transition Report on Form 20-F Transition Report on Form 11-K Transition Report on Form 10-Q Transition R |
|
| November 13, 2013 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q Quarterly Report UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ——————— FORM 10-Q ——————— (Mark One) þ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED September 30, 2013 OR ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO Commis |
|
| August 19, 2013 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ——————— FORM 10-Q ——————— (Mark One) þ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED June 30, 2013 OR ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO Commission File Number: 33-4 |
|
| August 14, 2013 |
- LATE FILING NOTIFICATION FORM xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. |
|
| August 2, 2013 |
August 2, 2013 Via E-Mail Ms. Chloe DiVita Chief Financial Officer Fona, Inc. 2575 Pearl Street, #220 Boulder, Colorado 80302 Re: Fona, Inc. Form 10-K for the year ended December 31, 2011 Filed March 30, 2012 File No. 000-54129 Dear Ms. DiVita: We have completed our review of your filing. We remind you that our comments or changes to disclosure in response to our comments do not foreclose the Comm |
|
| May 20, 2013 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q Quarterly Report UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ——————— FORM 10-Q ——————— (Mark One) þ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED March 31, 2013 OR ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO Commission |
|
| May 15, 2013 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 SEC FILE NUMBER NOTIFICATION OF LATE FILING CUSIP NUMBER (Check one): Form 10-K Form 20-F Form 11-K ü Form 10-Q Form 10-D Form N-SAR Form N-CSR For Period Ended: March 31, 2013 Transition Report on Form 10-K Transition Report on Form 20-F Transition Report on Form 11-K Transition Report on Form 10-Q Transition Repo |
|
| April 15, 2013 |
Annual Report UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ——————— FORM 10-K ——————— þ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended: December 31, 2012 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from: to Commission file number: 000 |
|
| April 9, 2013 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q/A Amendment No.1 Form 10Q/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q/A Amendment No.1 (Mark One) þ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED September 30, 2012 OR ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO Commission |
|
| April 9, 2013 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q/A Amendment No.1 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q/A Amendment No.1 (Mark One) þ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED March 31, 2012 OR ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO Commission File Number: 33 |
|
| April 9, 2013 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q/A Amendment No.1 Form 10Q/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q/A Amendment No.1 (Mark One) þ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED June 30, 2012 OR ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO Commission File |
|
| March 22, 2013 |
Notification of Late Filing UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. |
|
| February 19, 2013 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K /A Amendment No.1 Amendment No. 1 to Form 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K /A Amendment No.1 þ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2011 OR ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission f |
|
| February 19, 2013 |
Fona, Inc. 2575 Pearl St. Ste. 220 Boulder, CO 80302 February 15, 2013 VIA E-Mail Ms. Linda Cvrkel Securities and Exchange Commission Division of Corporate Finance 100 F Street NE Washington, DC 20549 RE: Fona, Inc. Form 10-K, for the year ended December 31, 2011 Filed March 30, 2012 File No.: 000-54129 Ladies and Gentlemen: Fona, Inc. (the “Company”) responds to the comments raised by the staff o |
|
| November 13, 2012 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ——————— FORM 10-Q ——————— (Mark One) þ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED September 30, 2012 OR ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO Commission File Number: |
|
| November 13, 2012 |
November 13, 2012 Via E-Mail Ms. Chloe DiVita Chief Financial Officer Fona, Inc. 2575 Pearl Street, #220 Boulder, Colorado 80302 Re: Fona, Inc. Form 10-K for the year ended December 31, 2011 Filed March 30, 2012 File No. 000-54129 Dear Ms. DiVita: We have reviewed your response letter dated November 1, 2012 and have the following comments. In some of our comments, we may ask you to provide us with |
|
| November 5, 2012 |
Fona, Inc Fona, Inc. 2575 Pearl St. Ste. 220 Boulder, CO 80302 November 1, 2012 VIA E-Mail Ms. Linda Cvrkel Securities and Exchange Commission Division of Corporate Finance 100 F Street NE Washington, DC 20549 RE: Fona, Inc. Form 10-K, for the year ended December 31, 2011 Filed March 30, 2012 File No.: 000-54129 Ladies and Gentlemen: Fona, Inc. (the “Company”) responds to the comments raised by th |
|
| September 14, 2012 |
September 14, 2012 Via E-Mail Ms. Chloe DiVita Chief Financial Officer Fona, Inc. 2575 Pearl Street, #220 Boulder, Colorado 80302 Re: Fona, Inc. Form 10-K for the year ended December 31, 2011 Filed March 30, 2012 File No. 000-54129 Dear Ms. DiVita: We have reviewed your filing and have the following comments. In some of our comments, we may ask you to provide us with information so we may better u |
|
| August 14, 2012 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q (Mark One) þ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED June 30 2012 OR ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO Commission File Number: 33-45904C FONA, INC. |
|
| May 15, 2012 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q (Mark One) [X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED March 31, 2012 OR [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO Commission File Number: 33-45904C FONA, |
|
| April 24, 2012 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K/A (Amendment No. 1) [X] ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2011 OR [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 000-53263 F |
|
| March 30, 2012 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K [X] ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2011 OR [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 000-53263 FONA, INC. (Exact nam |
|
| November 18, 2011 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q (Mark One) [X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED SEPTEMBER 30, 2011 OR [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO Commission File Number: 33-45904C - |
|
| November 14, 2011 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING (Check One): [ ]Form 10-K [ ]Form 20-F [ ]Form 11-K [X]Form 10-Q [ ]Form 10-D [ ]Form N-SAR [ ]Form N-CSR For Period Ended: September 30, 2011 [ ] Transition Report on Form 10-K [ ] Transition Report on Form 20-F [ ] Transition Report on Form 11-K [ ] Transition Report on Form 10-Q [ ] T |
|
| August 17, 2011 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Amendment No. 1 to Form 10-Q (Mark One) [X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED JUNE 30, 2011 OR [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO Commission File Numbe |
|
| August 15, 2011 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q (Mark One) [X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED JUNE 30, 2011 OR [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO Commission File Number: 33-45904C - FONA |
|
| May 13, 2011 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q (Mark One) [X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED MARCH 31, 2011 OR [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO Commission File Number: 33-45904C - FON |
|
| March 30, 2011 |
EX-4.1 4 fona1012gex41.txt SPECIMEN STOCK CERTIFICATE Exhibit 4.1 FONA, INC. INCORPORATED UNDER THE LAWS OF THE STATE OF NEVADA AUTHORIZED: 780,000,000 COMMON SHARES, $0.001 PAR VALUE PER SHARE NUMBER SHARES +-+ | CUSIP 34434 10 5| +-+ This Certifies That SEE REVERSE FOR SPECIMEN CERTAIN DEFINITIONS is the owner of Fully Paid and Non-Assessable Common Stock, $0.001 Par Value of FONA, INC. transfer |
|
| March 30, 2011 |
EX-3.1 2 fona1012gex31.txt ARTICLES OF INCORPORATION Exhibit 3.1 ARTICLES OF INCORPORATION OF FONA, INC. KNOW ALL BY THESE PRESENTS, that the undersigned, desiring to be incorporated as a Corporation in accordance with the laws of the State of Nevada, hereby certifies and adopts the following Articles of Incorporation, the terms whereof have been agreed upon to be equally obligatory upon the party |
|
| March 30, 2011 |
Exhibit 3.2 BYLAWS OF FONA,INC. ARTICLE I: OFFICES 1.1 REGISTERED OFFICE The registered office shall be in the City of Carson City, County of Carson City, State of Nevada. 1.2 ADDIT10NAL OFFICES The corporation may also have offices at such other places both within and without the State of Nevada as the Board of Directors may from time to time determine or the business of the corporation may requi |
|
| March 30, 2011 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K [X] ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2010 OR [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 000-53263 FONA, INC. (Exact nam |
|
| January 12, 2011 |
<1NG&.P_N$H-573$X:D8^JX;KS0QW?*G\KGZ6D MC"7>RW]C57?Z&X_?0=J;:$P(IY begin 644 filename1.pdf M)5!$1BTQ+C0-)>+CS],-"C0X(#`@;V)J#3P\+TQI;F5A-IB8&`09&!@V%LW(#0Q72]$96-O9&5087)M6]U="]/;F5#;VQU;6XO3T-07!E+T]#1SX^#65N9&]B:@TU,2`P(&]B:@T\/"]#%LP(#`@-C$R(#7!E+U1R=654>7!E+T9O;G1$97-C1K$0)SI5229J)%=P[<;&#!R=NEK\FCS)/E"QR<":3XAGNJ6=[ M$#!J^\!):`?$AR#PX.'CQ\EL"H9S-P5G,270O/TVG$]+`H^5X4>>[1(OBE@` M!#\^0P#$XL#5,L.)?+;47 MX+0#)S"F-O4AG@WL9-W.^-W`#O?-'5X?S2:$N!"GP.S`BP*(GP!/W9O07K |
|
| January 4, 2011 |
Fona, Inc. 5353 Manhattan Circle, Suite 101 Boulder, CO 80303 January 4, 2011 VIA EDGAR - - Mr. John Reynolds Securities and Exchange Commission Division of Corporate Finance 100 F Street NE Washington, DC 20549 RE: Fona, Inc. Form 10, Amendment 2 Filed December 10, 2010 Form 10-Q/A filed December 10, 2010 File No.: 0-54129 Ladies and Gentlemen: Fona, Inc. (the "Company") has today submitted to th |
|
| January 4, 2011 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q (Mark One) [X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED SEPTEMBER 30, 2010 OR [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO Commission File Number: 33-45904C - |
|
| December 29, 2010 |
":514)%XF,92;QG/E(I$GGI\JJZ_^N*`BEWXA:+PGXG17D,?=W+*3 MG#W>Q8OZ6I87+:B= begin 644 filename1.pdf M)5!$1BTQ+C0-)>+CS],-"CD@,"!O8FH-/#PO3&EN96%R:7IE9"`Q+TP@,S4U M.#$XZ/H!H`5I::0BDF8#8"H@Y&!@ZPH`T(Q!`0@P`&H0 M&'H-"F5N9'-T%LP(#`@-C$R(#%LP M(#`@-C$R(#7!E+U!A9V4^/@UE;F1O M8FH-,3(@,"!O8FH-/#PO6$]B:F5C=#P\+TEM,2`R-B`P(%(O26TR(#(X(#`@ M4CX^+T-O;&]R4W!A8V4\/"]#'0O26UA9V5#+TEM86=E25TO17AT1U-T M871E/#PO1U,Q(#(P(#`@4CX^/CX-96YD;V)J#3$S(#`@;V)J#3P\+U-U8G1Y M<&4O5')U951Y<&4O1F]N=$1E? |
|
| December 10, 2010 |
Exhibit 3.2 BYLAWS OF FONA,INC. ARTICLE I: OFFICES 1.1 REGISTERED OFFICE The registered office shall be in the City of Carson City, County of Carson City, State of Nevada. 1.2 ADDIT10NAL OFFICES The corporation may also have offices at such other places both within and without the State of Nevada as the Board of Directors may from time to time determine or the business of the corporation may requi |
|
| December 10, 2010 |
Exhibit 3.3 STOCK PURCHASE AGREEMENT This STOCK PURCHASE AGREEMENT ("Agreement") is entered into on December 22, 2008, by and between Michael Friess and Sanford Schwartz, Colorado residents ("Buyers"), and Fonahome Corporation, a Minnesota corporation (the "Company"). RECITALS A. The Company has determined that it is in the Company and its shareholders' best interest to sell 1,957,416 shares of th |
|
| December 10, 2010 |
U. S. Securities and Exchange Commission Washington, D.C. 20549 Form 10-12G GENERAL FORM FOR REGISTRATION OF SECURITIES OF SMALL BUSINESS ISSUERS Under Section 12(b) or 12(g) of the Securities Exchange Act of 1934 Fona Inc. (Name of Small Business Issuer in its charter) Nevada 41-1683548 - - (State or other jurisdiction of (I.R.S. Employer incorporation or organization) Identification No.) 5353 Ma |
|
| December 10, 2010 |
Fona, Inc. 5353 Manhattan Circle, Suite 101 Boulder, CO 80303 December 10, 2010 VIA EDGAR - - Mr. John Reynolds Securities and Exchange Commission Division of Corporate Finance 100 F Street NE Washington, DC 20549 RE: Fona, Inc. Form 10, Amendment 1 Filed November 19, 2010 File No.: 0-54129 Ladies and Gentlemen: Fona, Inc. (the "Company") has today submitted to the Securities and Exchange Commissi |
|
| December 10, 2010 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q (Mark One) [X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED SEPTEMBER 30, 2010 OR [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO Commission File Number: 33-45904C - |
|
| December 10, 2010 |
EX-3.1 2 fona1012gex31.txt ARTICLES OF INCORPORATION Exhibit 3.1 ARTICLES OF INCORPORATION OF FONA, INC. KNOW ALL BY THESE PRESENTS, that the undersigned, desiring to be incorporated as a Corporation in accordance with the laws of the State of Nevada, hereby certifies and adopts the following Articles of Incorporation, the terms whereof have been agreed upon to be equally obligatory upon the party |
|
| December 10, 2010 |
Exhibit 19.1 ASSIGNMENT FONAHOME Corporation ("Assignor") makes this complete and irrevocable Assignment of worldwide copyright rights, trademarks, and other assets to The Boosalis Group. Inc. ("Assignee") effective as of January 22, 2008. Assignor is the owner of (i) the computer software program known as the "FONAHOME or RENT411" system, (ii) the computer software used to operate the RENT411.com |
|
| December 10, 2010 |
EX-4.1 5 fona1012gex41.txt SPECIMEN STOCK CERTIFICATE Exhibit 4.1 FONA, INC. INCORPORATED UNDER THE LAWS OF THE STATE OF NEVADA AUTHORIZED: 780,000,000 COMMON SHARES, $0.001 PAR VALUE PER SHARE NUMBER SHARES +-+ | CUSIP 34434 10 5| +-+ This Certifies That SEE REVERSE FOR SPECIMEN CERTAIN DEFINITIONS is the owner of Fully Paid and Non-Assessable Common Stock, $0.001 Par Value of FONA, INC. transfer |
|
| December 3, 2010 |
begin 644 filename1.pdf M)5!$1BTQ+C0-)>+CS],-"C$V,B`P(&]B:@T\/"],:6YE87)I>F5D(#$O3"`T M-C')E9@T*,`T*)25%3T8-"B`@("`@("`@ M("`@#0HQ.#0@,"!O8FH-/#PO3&5N9W1H(#$X.2]#(#$X-2]&:6QT97(O1FQA M=&5$96-O9&4O22`R,3`O3"`Q-CDO4R`Y-SX^< M##H\'Y@8-,7?B#68.A0QO5@FP,!L^&J!L2A[XS3&"TP!9@UJC!>@MO(Q,$RW M9P`[F,$6B'D8&'J;(7S./4":A8'UZ,L`($.(@6'Y(I"3@/@[0(`!`)E?)ND- M"F5N9'-T7!E M+UA2968^/G-T-IB8N)A8&)@8!S%@P4SSATJ;@4(, |
|
| November 19, 2010 |
Exhibit 19.1 ASSIGNMENT FONAHOME Corporation ("Assignor") makes this complete and irrevocable Assignment of worldwide copyright rights, trademarks, and other assets to The Boosalis Group. Inc. ("Assignee") effective as of January 22, 2008. Assignor is the owner of (i) the computer software program known as the "FONAHOME or RENT411" system, (ii) the computer software used to operate the RENT411.com |
|
| November 19, 2010 |
Exhibit 3.3 STOCK PURCHASE AGREEMENT This STOCK PURCHASE AGREEMENT ("Agreement") is entered into on December 22, 2008, by and between Michael Friess and Sanford Schwartz, Colorado residents ("Buyers"), and Fonahome Corporation, a Minnesota corporation (the "Company"). RECITALS A. The Company has determined that it is in the Company and its shareholders' best interest to sell 1,957,416 shares of th |
|
| November 19, 2010 |
Exhibit 4.1 FONA, INC. INCORPORATED UNDER THE LAWS OF THE STATE OF NEVADA AUTHORIZED: 780,000,000 COMMON SHARES, $0.001 PAR VALUE PER SHARE NUMBER SHARES +-+ | CUSIP 34434 10 5| +-+ This Certifies That SEE REVERSE FOR SPECIMEN CERTAIN DEFINITIONS is the owner of Fully Paid and Non-Assessable Common Stock, $0.001 Par Value of FONA, INC. transferable on the books of this Corporation in person or by |
|
| November 19, 2010 |
Exhibit 3.2 BYLAWS OF FONA,INC. ARTICLE I: OFFICES 1.1 REGISTERED OFFICE The registered office shall be in the City of Carson City, County of Carson City, State of Nevada. 1.2 ADDIT10NAL OFFICES The corporation may also have offices at such other places both within and without the State of Nevada as the Board of Directors may from time to time determine or the business of the corporation may requi |
|
| November 19, 2010 |
Exhibit 3.1 ARTICLES OF INCORPORATION OF FONA, INC. KNOW ALL BY THESE PRESENTS, that the undersigned, desiring to be incorporated as a Corporation in accordance with the laws of the State of Nevada, hereby certifies and adopts the following Articles of Incorporation, the terms whereof have been agreed upon to be equally obligatory upon the party signing this instrument and all others who may from |
|
| November 19, 2010 |
Fona, Inc. 5353 Manhattan Circle, Suite 101 Boulder, CO 80303 November 19, 2010 VIA EDGAR - - Mr. John Reynolds Securities and Exchange Commission Division of Corporate Finance 100 F Street NE Washington, DC 20549 RE: Fona, Inc. Form 10 Filed September 23, 2010 File No.: 0-54129 Ladies and Gentlemen: Fona, Inc. (the "Company") has today submitted to the Securities and Exchange Commission (the "Com |
|
| November 19, 2010 |
U. S. Securities and Exchange Commission Washington, D.C. 20549 Form 10-12G GENERAL FORM FOR REGISTRATION OF SECURITIES OF SMALL BUSINESS ISSUERS Under Section 12(b) or 12(g) of the Securities Exchange Act of 1934 Fona Inc. (Name of Small Business Issuer in its charter) Nevada 41-1683548 - - (State or other jurisdiction of (I.R.S. Employer incorporation or organization) Identification No.) 5353 Ma |
|
| November 15, 2010 |
United States Securities and Exchange Commission Division of Corporation Finance Washington, D. |
|
| November 15, 2010 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q (Mark One) [X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED SEPTEMBER 30, 2010 OR [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO Commission File Number: 33-45904C - |
|
| November 2, 2010 |
United States Securities and Exchange Commission Division of Corporation Finance Washington, D. |
|
| October 20, 2010 | ||
| September 23, 2010 |
EX-3.2 3 fona1012gex32.txt BYLAWS Exhibit 3.2 BYLAWS OF FONA,INC. ARTICLE I: OFFICES 1.1 REGISTERED OFFICE The registered office shall be in the City of Carson City, County of Carson City, State of Nevada. 1.2 ADDIT10NAL OFFICES The corporation may also have offices at such other places both within and without the State of Nevada as the Board of Directors may from time to time determine or the bus |
|
| September 23, 2010 |
Exhibit 3.1 ARTICLES OF INCORPORATION OF FONA, INC. KNOW ALL BY THESE PRESENTS, that the undersigned, desiring to be incorporated as a Corporation in accordance with the laws of the State of Nevada, hereby certifies and adopts the following Articles of Incorporation, the terms whereof have been agreed upon to be equally obligatory upon the party signing this instrument and all others who may from |
|
| September 23, 2010 |
EX-4.1 5 fona1012gex41.txt SPECIMEN STOCK CERTIFICATE Exhibit 4.1 FONA, INC. INCORPORATED UNDER THE LAWS OF THE STATE OF NEVADA AUTHORIZED: 780,000,000 COMMON SHARES, $0.001 PAR VALUE PER SHARE NUMBER SHARES +-+ | CUSIP 34434 10 5| +-+ This Certifies That SEE REVERSE FOR SPECIMEN CERTAIN DEFINITIONS is the owner of Fully Paid and Non-Assessable Common Stock, $0.001 Par Value of FONA, INC. transfer |
|
| September 23, 2010 |
U. S. Securities and Exchange Commission Washington, D.C. 20549 Form 10-12G GENERAL FORM FOR REGISTRATION OF SECURITIES OF SMALL BUSINESS ISSUERS Under Section 12(b) or 12(g) of the Securities Exchange Act of 1934 Fona Inc. (Name of Small Business Issuer in its charter) Nevada 41-1683548 - - (State or other jurisdiction of (I.R.S. Employer incorporation or organization) Identification No.) 5353 Ma |
|
| September 23, 2010 |
EX-3.3 4 fona1012gex33.txt STOCK PURCHASE AGREEMENT Exhibit 3.3 STOCK PURCHASE AGREEMENT This STOCK PURCHASE AGREEMENT ("Agreement") is entered into on December 22, 2008, by and between Michael Friess and Sanford Schwartz, Colorado residents ("Buyers"), and Fonahome Corporation, a Minnesota corporation (the "Company"). RECITALS A. The Company has determined that it is in the Company and its shareh |
|
| September 23, 2010 |
EX-19.1 6 fona1012gex191.txt ASSIGNMENT AGREEMENT Exhibit 19.1 ASSIGNMENT FONAHOME Corporation ("Assignor") makes this complete and irrevocable Assignment of worldwide copyright rights, trademarks, and other assets to The Boosalis Group. Inc. ("Assignee") effective as of January 22, 2008. Assignor is the owner of (i) the computer software program known as the "FONAHOME or RENT411" system, (ii) the |
